欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0611/001
药品名称Ropivacain ReadyfusOR 2 mg/ml solution for infusion in administration system
活性成分
    • Ropivacaine hydrochloride 2.0 mg/ml
剂型SOLUTION FOR INFUSION IN ADMINISTRATION SYSTEM
上市许可持有人BioQ Pharma Ltd Garden Cottage, Hascombe Road GU8 4AE Godalming Surrey, United Kingdom
参考成员国 - 产品名称Austria (AT)
Ropivacain ReadyfusOR 2 mg/ml Infusionslösung im Applikationssystem
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
      Ropivacaine Readyfusor 2mg/ml solution pour perfusion en système d’administration
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
      Ropivacaine BioQ
    • Finland (FI)
    • Poland (PL)
      Ropivacaine BioQ
    • Czechia (CZ)
      Ropivacaine Cipla
    • Slovakia (SK)
      Ropivacaine Readyfusor
许可日期2017/11/08
最近更新日期2024/10/17
药物ATC编码
    • N01BB09 ropivacaine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase